Overview
Genetic non-syndromic central nervous system (CNS) malformation refers to a broad group of rare congenital structural abnormalities of the brain and/or spinal cord that occur in isolation — meaning they are not part of a recognized syndrome involving multiple organ systems. These malformations arise due to genetic mutations that disrupt normal CNS development during embryogenesis. Unlike syndromic forms, patients do not have the characteristic extra-CNS features (such as facial dysmorphism, skeletal anomalies, or organ malformations) that would point to a specific named syndrome. The central nervous system is the primary organ system affected, and malformations can include abnormalities of cortical development (such as lissencephaly, polymicrogyria, or heterotopia), cerebellar malformations, agenesis or dysgenesis of the corpus callosum, holoprosencephaly spectrum disorders, and neural tube defects, among others. Clinical features vary widely depending on the specific type and severity of the malformation but commonly include intellectual disability, developmental delay, seizures or epilepsy, motor impairment (including spasticity or hypotonia), and in some cases microcephaly or macrocephaly. Neurological deficits may range from mild learning difficulties to severe, life-limiting disability. Diagnosis is typically made through neuroimaging (MRI) and confirmed with genetic testing, which may identify causative mutations in a variety of genes involved in neuronal migration, proliferation, and differentiation. There is currently no curative treatment for genetic non-syndromic CNS malformations. Management is supportive and symptomatic, focusing on seizure control with antiepileptic medications, physical and occupational therapy for motor deficits, speech therapy, and educational support. Neurosurgical intervention may be required in select cases, such as for hydrocephalus or refractory epilepsy. A multidisciplinary approach involving neurologists, geneticists, rehabilitation specialists, and developmental pediatricians is essential for optimizing outcomes and quality of life.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Genetic non-syndromic central nervous system malformation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Genetic non-syndromic central nervous system malformation at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Genetic non-syndromic central nervous system malformation.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Genetic non-syndromic central nervous system malformation.
Community
No community posts yet. Be the first to share your experience with Genetic non-syndromic central nervous system malformation.
Start the conversation →Latest news about Genetic non-syndromic central nervous system malformation
No recent news articles for Genetic non-syndromic central nervous system malformation.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Genetic non-syndromic central nervous system malformation
What is Genetic non-syndromic central nervous system malformation?
Genetic non-syndromic central nervous system (CNS) malformation refers to a broad group of rare congenital structural abnormalities of the brain and/or spinal cord that occur in isolation — meaning they are not part of a recognized syndrome involving multiple organ systems. These malformations arise due to genetic mutations that disrupt normal CNS development during embryogenesis. Unlike syndromic forms, patients do not have the characteristic extra-CNS features (such as facial dysmorphism, skeletal anomalies, or organ malformations) that would point to a specific named syndrome. The central n
At what age does Genetic non-syndromic central nervous system malformation typically begin?
Typical onset of Genetic non-syndromic central nervous system malformation is neonatal. Age of onset can vary across affected individuals.